TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. AU - Hao, Y. AU - Xu, J. AU - Thun, M. J. PY - 2008 DA - 2008// TI - Cancer statistics, 2009 JO - CA Cancer J Clin VL - 59 UR - https://doi.org/10.3322/caac.20006 DO - 10.3322/caac.20006 ID - Jemal2008 ER - TY - STD TI - A clinical evaluation of the International Lymphoma Study Group classification of non Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997, 89: 3909-3918. ID - ref2 ER - TY - JOUR AU - Young, G. A. AU - Iland, H. J. PY - 2007 DA - 2007// TI - Clinical perspectives in lymphoma JO - Intern Med J VL - 37 UR - https://doi.org/10.1111/j.1445-5994.2007.01402.x DO - 10.1111/j.1445-5994.2007.01402.x ID - Young2007 ER - TY - JOUR AU - Tsartsidze, E. AU - Betaneli, M. AU - Sharikadze, N. AU - Shavidze, N. AU - Seskuria, N. PY - 2007 DA - 2007// TI - Treatment of aggressive non-Hodgkin's lymphomas JO - Georgian Med News VL - 145 ID - Tsartsidze2007 ER - TY - JOUR AU - Schulz, H. AU - Bohlius, J. AU - Skoetz, N. AU - Trelle, S. AU - Kober, T. AU - Reiser, M. AU - Dreyling, M. AU - Herold, M. AU - Schwarzer, G. AU - Hallek, M. AU - Engert, A. PY - 2007 DA - 2007// TI - Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma JO - Cochrane Database Syst Rev VL - 4 ID - Schulz2007 ER - TY - JOUR AU - Buske, C. AU - Weigert, O. AU - Dreyling, M. AU - Unterhalt, M. AU - Hiddemann, W. PY - 2006 DA - 2006// TI - Current status and perspective of antibody therapy in follicular lymphoma JO - Haematologica VL - 91 ID - Buske2006 ER - TY - JOUR AU - Bernal-Mizrachi, L. AU - Lovly, C. M. AU - Ratner, L. PY - 2006 DA - 2006// TI - The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphoma JO - Proc Natl Acad Sci USA VL - 103 UR - https://doi.org/10.1073/pnas.0507809103 DO - 10.1073/pnas.0507809103 ID - Bernal-Mizrachi2006 ER - TY - JOUR AU - Hayden, M. S. AU - Ghosh, S. PY - 2008 DA - 2008// TI - Shared principles in NF-kB signaling JO - Cell VL - 132 UR - https://doi.org/10.1016/j.cell.2008.01.020 DO - 10.1016/j.cell.2008.01.020 ID - Hayden2008 ER - TY - JOUR AU - Basseres, D. S. AU - Baldwin, A. S. PY - 2006 DA - 2006// TI - Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression JO - Oncogene VL - 25 UR - https://doi.org/10.1038/sj.onc.1209942 DO - 10.1038/sj.onc.1209942 ID - Basseres2006 ER - TY - JOUR AU - Mayo, M. W. AU - Baldwin, A. S. PY - 2000 DA - 2000// TI - The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance JO - Biochim Biophys Acta VL - 1470 ID - Mayo2000 ER - TY - JOUR AU - Escarcega, R. O. AU - Fuentes-Alexandro, S. AU - García-Carrasco, M. AU - Gatica, A. AU - Zamora, A. PY - 2007 DA - 2007// TI - The transcription factor nuclear factor-kappa B and cancer JO - Clin Oncol (R Coll Radiol) VL - 19 UR - https://doi.org/10.1016/j.clon.2006.11.013 DO - 10.1016/j.clon.2006.11.013 ID - Escarcega2007 ER - TY - JOUR AU - Heckman, C. A. AU - Mehew, J. W. AU - Boxer, L. M. PY - 2002 DA - 2002// TI - NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205483 DO - 10.1038/sj.onc.1205483 ID - Heckman2002 ER - TY - JOUR AU - Heckman, C. A. AU - Cao, T. AU - Somsouk, L. AU - Duan, H. AU - Mehew, J. W. AU - Zhang, C. Y. AU - Boxer, L. M. PY - 2003 DA - 2003// TI - Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2 JO - Cancer Res VL - 63 ID - Heckman2003 ER - TY - JOUR AU - Duan, H. AU - Heckman, C. A. AU - Boxer, L. M. PY - 2007 DA - 2007// TI - The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210061 DO - 10.1038/sj.onc.1210061 ID - Duan2007 ER - TY - JOUR AU - Baldwin, A. S. PY - 1996 DA - 1996// TI - The NF-kappa B and I kappa B proteins: new discoveries and insights JO - Annu Rev Immunol VL - 14 UR - https://doi.org/10.1146/annurev.immunol.14.1.649 DO - 10.1146/annurev.immunol.14.1.649 ID - Baldwin1996 ER - TY - JOUR AU - Karin, M. PY - 2006 DA - 2006// TI - Nuclear factor-kappaB in cancer development and progression JO - Nature VL - 441 UR - https://doi.org/10.1038/nature04870 DO - 10.1038/nature04870 ID - Karin2006 ER - TY - JOUR AU - Baldwin, A. S. PY - 2001 DA - 2001// TI - Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB JO - J Clin Invest VL - 107 UR - https://doi.org/10.1172/JCI11991 DO - 10.1172/JCI11991 ID - Baldwin2001 ER - TY - JOUR AU - Jost, P. J. AU - Ruland, J. PY - 2007 DA - 2007// TI - Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications JO - Blood VL - 109 ID - Jost2007 ER - TY - JOUR AU - Braddock, M. PY - 2007 DA - 2007// TI - 11th annual Inflammatory and Immune Diseases Drug Discovery and Development Summit 12-13 March 2007, San Francisco, USA JO - Expert Opi Investig Drugs VL - 16 UR - https://doi.org/10.1517/13543784.16.6.909 DO - 10.1517/13543784.16.6.909 ID - Braddock2007 ER - TY - JOUR AU - Hideshima, T. AU - Neri, P. AU - Tassone, P. AU - Yasui, H. AU - Ishitsuka, K. AU - Raje, N. AU - Chauhan, D. AU - Podar, K. AU - Mitsiades, C. AU - Dang, L. AU - Munshi, N. AU - Richardson, P. AU - Schenkein, D. AU - Anderson, K. C. PY - 2006 DA - 2006// TI - MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-2501 DO - 10.1158/1078-0432.CCR-05-2501 ID - Hideshima2006 ER - TY - JOUR AU - Mohammad, R. M. AU - Kucuk, O. AU - Aboukameel, A. AU - Ibrahim, D. AU - Doerge, D. R. AU - Sarkar, F. AU - Al-Katib, A. M. PY - 2003 DA - 2003// TI - Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy JO - Mol Cancer Ther VL - 2 ID - Mohammad2003 ER - TY - JOUR AU - Mujagic, H. AU - Chen, S. S. AU - Geist, R. AU - Occhipinti, S. J. AU - Conger, B. M. AU - Smith, C. A. AU - Schuette, W. H. AU - Shackney, S. E. PY - 1983 DA - 1983// TI - Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing Sarcoma 180 cells JO - Cancer Res VL - 43 ID - Mujagic1983 ER - TY - JOUR AU - Shinwari, Z. AU - Manogaran, P. S. AU - Alrokayan, A. AU - Al-Hussein, K. A. AU - Aboussekhra, A. PY - 2008 DA - 2008// TI - Vincristine and lomustine induce apoptosis and p21(WAF1) up-regulation in medulloblastoma and normal human epithelial and fibroblast cells JO - J Neuro Oncol VL - 87 UR - https://doi.org/10.1007/s11060-007-9502-4 DO - 10.1007/s11060-007-9502-4 ID - Shinwari2008 ER - TY - JOUR AU - Wang, L. AU - MacDonald, R. C. PY - 2004 DA - 2004// TI - Effects of microtubule-depolymerizing agents on the transfection of cultured vascular smooth muscle cells: enhanced expression with free drug and especially with drug-gene lipoplexes JO - Mol Ther VL - 9 UR - https://doi.org/10.1016/j.ymthe.2004.02.009 DO - 10.1016/j.ymthe.2004.02.009 ID - Wang2004 ER - TY - JOUR AU - Mohammad, R. AU - Abubakr, Y. AU - Dan, M. AU - Aboukameel, A. AU - Chow, C. AU - Mohamed, A. AU - Hamdy, N. AU - Al-Katib, A. PY - 2002 DA - 2002// TI - Bcl-2 Antisense oligonucleotides are effective against systemic but not central nervous system disease in Severe Combined Immuno Deficient mice bearing human t(14;18) follicular lymphoma JO - Clin Cancer Res VL - 8 ID - Mohammad2002 ER - TY - JOUR AU - Garcia, M. G. AU - Alaniz, L. AU - Lopes, E. C. AU - Blanco, G. AU - Hajos, S. E. AU - Alvarez, E. PY - 2005 DA - 2005// TI - Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines JO - Leuk Res VL - 29 UR - https://doi.org/10.1016/j.leukres.2005.05.004 DO - 10.1016/j.leukres.2005.05.004 ID - Garcia2005 ER - TY - JOUR AU - Greten, F. R. AU - Karin, M. PY - 2004 DA - 2004// TI - The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer JO - Cancer Lett VL - 206 UR - https://doi.org/10.1016/j.canlet.2003.08.029 DO - 10.1016/j.canlet.2003.08.029 ID - Greten2004 ER - TY - JOUR AU - Karin, M. AU - Yamamoto, Y. AU - Wang, Q. M. PY - 2004 DA - 2004// TI - The IKK NF-kappa B system: a treasure trove for drug development JO - Nat Rev Drug Discov VL - 3 UR - https://doi.org/10.1038/nrd1279 DO - 10.1038/nrd1279 ID - Karin2004 ER - TY - JOUR AU - Wen, D. AU - Nong, Y. AU - Morgan, J. G. AU - Gangurde, P. AU - Bielecki, A. AU - Dasilva, J. AU - Keaveney, M. AU - Cheng, H. AU - Fraser, C. AU - Schopf, L. AU - Hepperle, M. AU - Harriman, G. AU - Jaffee, B. D. AU - Ocain, T. D. AU - Xu, Y. PY - 2006 DA - 2006// TI - A selective small molecule IκB kinase B inhibitor blocks nuclear factor κB- mediated inflammatory responses in human fibroblast- like synviocytes, Chondrocytes, and Mast Cells JO - J Pharmacol Exp Ther VL - 317 UR - https://doi.org/10.1124/jpet.105.097584 DO - 10.1124/jpet.105.097584 ID - Wen2006 ER - TY - JOUR AU - Nakajima, H. AU - Fujiwara, H. AU - Furuichi, Y. AU - Tanaka, K. AU - Shimbara, N. PY - 2008 DA - 2008// TI - A novel small-molecule inhibitor of NF-kappaB signaling JO - Biochem Biophys Res Commun VL - 368 UR - https://doi.org/10.1016/j.bbrc.2008.01.166 DO - 10.1016/j.bbrc.2008.01.166 ID - Nakajima2008 ER - TY - JOUR AU - Huang, Y. AU - Fang, Y. AU - Wu, J. AU - Dziadyk, J. M. AU - Zhu, X. AU - Sui, M. AU - Fan, W. PY - 2004 DA - 2004// TI - Regulation of Vinca alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells JO - Mol Can Ther VL - 3 ID - Huang2004 ER - TY - JOUR AU - Chen, X. AU - Kandasamy, K. AU - Srivastava, R. K. PY - 2003 DA - 2003// TI - Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling JO - Cancer Res VL - 63 ID - Chen2003 ER - TY - JOUR AU - Wuerzberger-Davis, S. M. AU - Chang, P. Y. AU - Berchtold, C. AU - Miyamoto, S. PY - 2005 DA - 2005// TI - Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction JO - Mol Cancer Res VL - 3 UR - https://doi.org/10.1158/1541-7786.MCR-05-0028 DO - 10.1158/1541-7786.MCR-05-0028 ID - Wuerzberger-Davis2005 ER - TY - JOUR AU - Bharti, A. C. AU - Takada, Y. AU - Aggarwal, B. B. PY - 2003 DA - 2003// TI - Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-05-1320 DO - 10.1182/blood-2002-05-1320 ID - Bharti2003 ER - TY - JOUR AU - Sanda, T. AU - Iida, S. AU - Ogura, H. AU - Asamitsu, K. AU - Murata, T. AU - Bacon, K. B. AU - Ueda, R. AU - Okamoto, T. PY - 2005 DA - 2005// TI - Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1936 DO - 10.1158/1078-0432.CCR-04-1936 ID - Sanda2005 ER - TY - JOUR AU - Mohammad, R. M. AU - Mohamed, A. N. AU - Smith, M. R. AU - Jawadi, N. S. AU - Al-Katib, A. PY - 1993 DA - 1993// TI - A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11) JO - Cancer Gene Cytogene VL - 70 UR - https://doi.org/10.1016/0165-4608(93)90132-6 DO - 10.1016/0165-4608(93)90132-6 ID - Mohammad1993 ER - TY - JOUR AU - Al-Katib, A. M. AU - Smith, M. R. AU - Kamanda, W. S. AU - Pettit, G. R. AU - Hamdan, M. AU - Mohamed, A. N. AU - Chelladurai, B. AU - Mohammad, R. M. PY - 1998 DA - 1998// TI - Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts JO - Clin Cancer Res VL - 4 ID - Al-Katib1998 ER - TY - JOUR AU - Darzynkiewicz, Z. AU - Galkowski, D. AU - Zhao, H. PY - 2008 DA - 2008// TI - Analysis of apoptosis by cytometry using TUNEL assay JO - Methods VL - 44 UR - https://doi.org/10.1016/j.ymeth.2007.11.008 DO - 10.1016/j.ymeth.2007.11.008 ID - Darzynkiewicz2008 ER - TY - JOUR AU - Mohammad, R. M. AU - Wayng, S. AU - Aboukameel, A. AU - Chen, B. AU - Wu, X. AU - Chen, J. AU - Al-Katib, A. PY - 2005 DA - 2005// TI - Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL[(--)-gossypol] against diffuse large cell lymphoma JO - Mol Cancer Ther VL - 4 ID - Mohammad2005 ER - TY - JOUR AU - Chou, T. C. AU - Talalay, P. PY - 1984 DA - 1984// TI - Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors JO - Adv Enzyme Regul VL - 22 UR - https://doi.org/10.1016/0065-2571(84)90007-4 DO - 10.1016/0065-2571(84)90007-4 ID - Chou1984 ER -